Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications

Abstract

Recently, the Food and Drug Administration (FDA) issued an advisory stating that atypical antipsychotic medications increase mortality among elderly patients. However, the advisory did not apply to conventional antipsychotic medications; the risk of death with these older agents is not known.